Sirtuin
From Wikipedia, the free encyclopedia
Sirtuin is a class of enzyme, specifically NAD-dependent histone deacetylases (class 3), found in both prokaryotes and eukaryotes. They have been known to affect cellular metabolism through selective gene expression in eukaryotes (plants and animals). The name comes from silent mating type information regulation two[1], the gene responsible for cellular regulation in yeast.
Contents |
[edit] Sirtuins in organisms
[edit] Sirtuins in lower eukaryotes
In yeast, roundworms, and fruitflies[2], sir2 is the name of the sirtuin-type enzyme. This research was begun in 1991 by Leonard Guarente of Harvard Medical School [3][4].
[edit] Sirtuins in higher eukaryotes
[edit] Sirtuins types
Sirtuins are classed according to their sequence of amino acids. Prokaryotics are in class U. In yeast (a lower eukaryote), sirtuin was initially found and named sir2. In more complex mammals there are seven known enzymes which act as on cellular regulation as sir2 does in yeast. These genes are designated as belonging to different classes, depending on their amino acid sequence structure.[5][6]
Class | Human name | Yeast name | Mouse name |
---|---|---|---|
Ia | SIRT1[7] | Sir2 or Sir2p, Hst1 or Hst1p | Sir2-beta |
Ib | SIRT2, SIRT3 | Hst2 or Hst2p | Sir2l2, Sir2l3 |
Ic | Hst3 or Hst3p, Hst4 or Hst4p | ||
II | SIRT4 | SIRT4 | |
III | SIRT5 | SIRT5 | |
IVa | SIRT6 [8] | SIRT6 | |
IVb | SIRT7 | SIRT7 | |
U< | Found only in Gram-positive bacteria |
Sirtuin list based on North/Verdin diagram.[9]
[edit] Companies associated with the sirtuin enzymes
[edit] Elixir Pharmaceuticals
Founded by Leonard Guarente of Harvard Medical School, with Cynthia Kenyon of the University of California at San Francisco, with the intentions of treating aging through drugs which affect metabolism.[10]
[edit] Sirtris
Sirtris[11] was co-founded by David Sinclair[12] of the Harvard Medical School, and Dr. Christoph Westphal is the CEO. Sirtris is associated with the World Transhumanist Association.[13]
[edit] See also
[edit] References
- ^ EntrezGene 23410
- ^ Patient Care, "Do antiaging approaches promote longevity?" By: David A. Sinclair, PhD, Evan W. Kligman, MD.
- ^ "The quest for a way around aging", Nov. 8 2006, International Herald Tribune. By Nicholas Wade / The New York Times.
- ^ Massachusetts Institute of Technology, News Office: "MIT researchers uncover new information about anti-aging gene."
- ^ Frye R (2000). "Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins". Biochem Biophys Res Commun 273 (2): 793-8. PMID 10873683.
- ^ Dryden S, Nahhas F, Nowak J, Goustin A, Tainsky M (2003). "Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle". Mol Cell Biol 23 (9): 3173-85. PMID 12697818.
- ^ http://focus.hms.harvard.edu/2005/Sep2_2005/research_briefs.shtml
- ^ Mostoslavsky R et al. (2006). "Genomic instability and aging-like phenotype in the absence of mammalian SIRT6". Cell 124 (2): 315-29. PMID 16439206.
- ^ North B, Verdin E (2004). "Sirtuins: Sir2-related NAD-dependent protein deacetylases". Genome Biol 5 (5): 224. PMID 15128440.
- ^ http://www.elixirpharm.com/
- ^ http://sirtrispharma.com/Home/tabid/3662/Default.aspx
- ^ Patient Care article by David A. Sinclair, PhD and Evan W. Kligman, MD.
- ^ http://www.transhumanism.org/index.php/WTA/about